News

Filter

Current filters:

Methylnaltrexone Bromide

1 to 9 of 13 results

Scottish regulators give nod to Bayer's Xarelto, Wyeth's Relistor and B-MS' Reyataz

15-12-2008

The Scottish Medicines Consortium, the body responsible for recommending drugs to the National Health…

AspirinAtazanavir SulfateBayerBayerBristol-Myers SquibbMethylnaltrexone BromideRelistorReyatazWyeth

Strong Ph III for Relistor in non-cancer OIC

08-12-2008

The USA's Wyeth Pharmaceuticals and Progenics Pharmaceuticals say that a Phase III study of their Relistor…

Amino AcidsInjectionMethylnaltrexone BromidePhysostigmine SalicylateRelistorWyeth

Progenics gets Australian appro for Relistor

24-11-2008

The USA's Progenics has received approval for its Wyeth-marketed drug Relistor (methylnaltrexone bromide…

Amino AcidsInjectionMethylnaltrexone BromidePhysostigmine SalicylateRelistorWyeth

Ono licenses Progenics' OIC drug in Japan

27-10-2008

Japanese drugmaker Ono has acquired the local rights to Progenics' Relistor (methylnaltrexone bromide),…

Methylnaltrexone BromideNystatinOralRelistorWyeth

Japan MHLW Study C'ttee views developments

13-10-2008

The Study Committee on the Use of Unapproved Drugs within Japan's Ministry of Health, Labor and Welfare…

AmgenAnakinraKineretMethylnaltrexone BromideRelistorWyeth

Wyeth/Progenics' Reslitor approved in EU

14-07-2008

Drug major Wyeth and fellow USA-based Progenics Pharmaceuticals have received European marketing approval…

Amino AcidsInjectionMethylnaltrexone BromidePhysostigmine SalicylateRelistorWyeth

1 to 9 of 13 results

Back to top